$471 Million is the total value of Ghost Tree Capital, LLC's 63 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 89.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XBI | SPDR SERIES TRUSTput | $30,300,000 | +12.2% | 350,000 | 0.0% | 6.43% | +14.6% | |
| IMMU | Buy | IMMUNOMEDICS INC | $27,218,000 | +156.9% | 1,946,946 | +62.2% | 5.78% | +162.5% |
| ZGNX | New | ZOGENIX INCput | $22,783,000 | – | 650,000 | +100.0% | 4.84% | – |
| ZGNX | Buy | ZOGENIX INC | $21,030,000 | +1350.3% | 600,000 | +500.0% | 4.47% | +1383.7% |
| AVXS | New | AVEXIS INCput | $19,346,000 | – | 200,000 | +100.0% | 4.11% | – |
| DBVT | Sell | DBV TECHNOLOGIES S Asponsored adr | $17,862,000 | +17.7% | 420,886 | -1.0% | 3.79% | +20.2% |
| DBVT | New | DBV TECHNOLOGIES S Aput | $17,125,000 | – | 403,500 | +100.0% | 3.64% | – |
| ALXN | ALEXION PHARMACEUTICALS INC | $14,029,000 | +15.3% | 100,000 | 0.0% | 2.98% | +17.8% | |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $13,788,000 | +99.8% | 225,000 | +50.0% | 2.93% | +104.2% |
| XLRN | Buy | ACCELERON PHARMA INC | $13,062,000 | +377.6% | 350,000 | +288.9% | 2.77% | +388.4% |
| NVRO | Sell | NEVRO CORP | $10,451,000 | -14.9% | 115,000 | -30.3% | 2.22% | -13.1% |
| ENTL | Buy | ENTELLUS MED INC | $10,365,000 | +66.9% | 561,510 | +49.7% | 2.20% | +70.5% |
| INSM | Sell | INSMED INC | $10,125,000 | +24.2% | 324,400 | -31.7% | 2.15% | +26.9% |
| AVXS | Sell | AVEXIS INC | $10,112,000 | -35.2% | 104,539 | -45.0% | 2.15% | -33.8% |
| BMY | Sell | BRISTOL MYERS SQUIBB COcall | $9,561,000 | -42.9% | 150,000 | -50.0% | 2.03% | -41.7% |
| TMO | New | THERMO FISHER SCIENTIFIC INC | $9,460,000 | – | 50,000 | +100.0% | 2.01% | – |
| INSM | New | INSMED INCcall | $9,363,000 | – | 300,000 | +100.0% | 1.99% | – |
| SAGE | New | SAGE THERAPEUTICS INCput | $9,345,000 | – | 150,000 | +100.0% | 1.98% | – |
| GNMK | Buy | GENMARK DIAGNOSTICS INC | $9,149,000 | -6.3% | 950,000 | +15.2% | 1.94% | -4.2% |
| ZBH | Sell | ZIMMER BIOMET HLDGS INC | $8,782,000 | -14.5% | 75,000 | -6.2% | 1.86% | -12.6% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $8,022,000 | +65.4% | 275,000 | +57.1% | 1.70% | +69.0% |
| PBYI | Sell | PUMA BIOTECHNOLOGY INC | $7,784,000 | -40.6% | 65,000 | -56.7% | 1.65% | -39.3% |
| GBT | New | GLOBAL BLOOD THERAPEUTICS IN | $7,763,000 | – | 250,000 | +100.0% | 1.65% | – |
| VRTX | New | VERTEX PHARMACEUTICALS INC | $7,602,000 | – | 50,000 | +100.0% | 1.61% | – |
| ASND | New | ASCENDIS PHARMA A Ssponsored adr | $7,250,000 | – | 200,000 | +100.0% | 1.54% | – |
| ONCE | Buy | SPARK THERAPEUTICS INC | $7,133,000 | +241.1% | 80,000 | +128.6% | 1.52% | +248.3% |
| IRTC | Sell | IRHYTHM TECHNOLOGIES INC | $7,004,000 | +9.9% | 135,000 | -10.0% | 1.49% | +12.2% |
| RXDX | New | IGNYTA INC | $6,793,000 | – | 550,000 | +100.0% | 1.44% | – |
| PDCO | New | PATTERSON COMPANIES INC | $6,184,000 | – | 160,000 | +100.0% | 1.31% | – |
| ICPT | New | INTERCEPT PHARMACEUTICALS INcall | $5,804,000 | – | 100,000 | +100.0% | 1.23% | – |
| ARGX | Buy | ARGENX SEsponsored adr | $5,710,000 | +37.2% | 252,534 | +28.7% | 1.21% | +40.2% |
| AQXP | Buy | AQUINOX PHARMACEUTICALS INC | $5,676,000 | +34.5% | 400,000 | +33.3% | 1.20% | +37.4% |
| NSTG | Sell | NANOSTRING TECHNOLOGIES INC | $5,580,000 | -3.6% | 345,284 | -1.3% | 1.18% | -1.5% |
| GWPH | Sell | GW PHARMACEUTICALS PLCads | $5,075,000 | -59.5% | 50,000 | -60.0% | 1.08% | -58.6% |
| AIMT | Sell | AIMMUNE THERAPEUTICS INC | $4,958,000 | -3.5% | 200,000 | -20.0% | 1.05% | -1.4% |
| BMY | New | BRISTOL MYERS SQUIBB CO | $4,781,000 | – | 75,000 | +100.0% | 1.02% | – |
| SRPT | New | SAREPTA THERAPEUTICS INC | $4,536,000 | – | 100,000 | +100.0% | 0.96% | – |
| JUNO | Sell | JUNO THERAPEUTICS INC | $4,486,000 | -45.4% | 100,000 | -63.6% | 0.95% | -44.2% |
| MRK | New | MERCK & CO INC | $4,162,000 | – | 65,000 | +100.0% | 0.88% | – |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $4,112,000 | – | 35,000 | +100.0% | 0.87% | – |
| ACAD | New | ACADIA PHARMACEUTICALS INCcall | $4,106,000 | – | 109,000 | +100.0% | 0.87% | – |
| INCY | New | INCYTE CORP | $4,086,000 | – | 35,000 | +100.0% | 0.87% | – |
| VRAY | Sell | VIEWRAY INC | $4,032,000 | -16.9% | 700,000 | -6.7% | 0.86% | -15.2% |
| FXB | Sell | CURRENCYSHS BRIT POUND STERbrit pound ste | $3,923,000 | -39.2% | 30,100 | -40.9% | 0.83% | -37.9% |
| AIMT | New | AIMMUNE THERAPEUTICS INCcall | $3,719,000 | – | 150,000 | +100.0% | 0.79% | – |
| NEOS | Sell | NEOS THERAPEUTICS INC | $3,660,000 | +0.3% | 400,000 | -20.0% | 0.78% | +2.4% |
| AERI | New | AERIE PHARMACEUTICALS INC | $3,645,000 | – | 75,000 | +100.0% | 0.77% | – |
| RARX | Buy | RA PHARMACEUTICALS INC | $3,431,000 | +115.4% | 235,000 | +176.5% | 0.73% | +120.2% |
| FOLD | New | AMICUS THERAPEUTICS INC | $3,016,000 | – | 200,000 | +100.0% | 0.64% | – |
| KDMN | New | KADMON HLDGS INC | $2,848,000 | – | 850,000 | +100.0% | 0.60% | – |
| RIGL | RIGEL PHARMACEUTICALS INC | $2,794,000 | -7.0% | 1,100,000 | 0.0% | 0.59% | -5.0% | |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS | $2,620,000 | -30.2% | 500,000 | -25.9% | 0.56% | -28.7% |
| ICPT | New | INTERCEPT PHARMACEUTICALS IN | $2,031,000 | – | 35,000 | +100.0% | 0.43% | – |
| PTCT | Sell | PTC THERAPEUTICS INC | $2,001,000 | -45.4% | 100,000 | -50.0% | 0.42% | -44.2% |
| PTCT | New | PTC THERAPEUTICS INCcall | $2,001,000 | – | 100,000 | +100.0% | 0.42% | – |
| IRIX | Sell | IRIDEX CORP | $1,869,000 | -24.4% | 199,519 | -20.2% | 0.40% | -22.8% |
| NUVA | Sell | NUVASIVE INC | $1,664,000 | -78.4% | 30,000 | -70.0% | 0.35% | -77.9% |
| EXEL | New | EXELIXIS INC | $1,296,000 | – | 53,500 | +100.0% | 0.28% | – |
| DCPH | New | DECIPHERA PHARMACEUTICALS IN | $1,223,000 | – | 64,410 | +100.0% | 0.26% | – |
| New | NABRIVA THERAPEUTICS PLC | $983,000 | – | 120,000 | +100.0% | 0.21% | – | |
| QTNT | Sell | QUOTIENT LTD | $924,000 | -58.2% | 187,450 | -37.5% | 0.20% | -57.3% |
| AXGT | Sell | AXOVANT SCIENCES LTD | $688,000 | -83.0% | 100,000 | -42.9% | 0.15% | -82.7% |
| VSAR | New | VERSARTIS INC | $674,000 | – | 275,000 | +100.0% | 0.14% | – |
| FOMX | Exit | FOAMIX PHARMACEUTICALS LTD | $0 | – | -125,000 | -100.0% | -0.12% | – |
| BOLD | Exit | AUDENTES THERAPEUTICS INC | $0 | – | -50,000 | -100.0% | -0.20% | – |
| EPZM | Exit | EPIZYME INC | $0 | – | -150,000 | -100.0% | -0.47% | – |
| RVNC | Exit | REVANCE THERAPEUTICS INC | $0 | – | -89,295 | -100.0% | -0.49% | – |
| ITCI | Exit | INTRA CELLULAR THERAPIES INC | $0 | – | -200,000 | -100.0% | -0.52% | – |
| SNDX | Exit | SYNDAX PHARMACEUTICALS INC | $0 | – | -200,000 | -100.0% | -0.58% | – |
| ALDR | Exit | ALDER BIOPHARMACEUTICALS INC | $0 | – | -250,000 | -100.0% | -0.60% | – |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -70,000 | -100.0% | -0.74% | – |
| KTWO | Exit | K2M GROUP HLDGS INC | $0 | – | -150,000 | -100.0% | -0.76% | – |
| CBAY | Exit | CYMABAY THERAPEUTICS INC | $0 | – | -650,000 | -100.0% | -0.78% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -50,000 | -100.0% | -0.83% | – |
| IOVA | Exit | IOVANCE BIOTHERAPEUTICS INC | $0 | – | -550,000 | -100.0% | -0.84% | – |
| ATRA | Exit | ATARA BIOTHERAPEUTICS INC | $0 | – | -350,000 | -100.0% | -1.02% | – |
| KITE | Exit | KITE PHARMA INCcall | $0 | – | -50,000 | -100.0% | -1.08% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -75,000 | -100.0% | -1.10% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INCcall | $0 | – | -45,000 | -100.0% | -1.14% | – |
| NVDQ | Exit | NOVADAQ TECHNOLOGIES INC | $0 | – | -500,000 | -100.0% | -1.22% | – |
| ITCI | Exit | INTRA CELLULAR THERAPIES INCcall | $0 | – | -500,000 | -100.0% | -1.29% | – |
| NXTM | Exit | NXSTAGE MEDICAL INC | $0 | – | -260,000 | -100.0% | -1.36% | – |
| TSRO | Exit | TESARO INC | $0 | – | -50,000 | -100.0% | -1.45% | – |
| ENTA | Exit | ENANTA PHARMACEUTICALS INC | $0 | – | -200,000 | -100.0% | -1.50% | – |
| EXEL | Exit | EXELIXIS INCput | $0 | – | -300,000 | -100.0% | -1.54% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -275,000 | -100.0% | -1.59% | – |
| SPNC | Exit | SPECTRANETICS CORPcall | $0 | – | -200,000 | -100.0% | -1.60% | – |
| ACOR | Exit | ACORDA THERAPEUTICS INC | $0 | – | -400,000 | -100.0% | -1.64% | – |
| ENDP | Exit | ENDO INTL PLC | $0 | – | -750,000 | -100.0% | -1.74% | – |
| PTLA | Exit | PORTOLA PHARMACEUTICALS INC | $0 | – | -200,000 | -100.0% | -2.34% | – |
| MRK | Exit | MERCK & CO INCcall | $0 | – | -200,000 | -100.0% | -2.66% | – |
| SGEN | Exit | SEATTLE GENETICS INC | $0 | – | -300,000 | -100.0% | -3.23% | – |
| PTLA | Exit | PORTOLA PHARMACEUTICALS INCput | $0 | – | -400,000 | -100.0% | -4.67% | – |
| CLVS | Exit | CLOVIS ONCOLOGY INCcall | $0 | – | -301,000 | -100.0% | -5.86% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
| 13F-HR | 2021-11-15 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.